US 12,227,513 B2
Salt and crystalline form of furopyrimidine compound and pharmaceutical use thereof
Minhee Lee, Seongnam-si (KR); Seon-Mi Kim, Seongnam-si (KR); and Hun-Taek Kim, Seongnam-si (KR)
Assigned to TIUMBIO CO., LTD., Seongnam-si (KR)
Appl. No. 17/296,836
Filed by TIUMBIO CO., LTD., Seongnam-si (KR)
PCT Filed Oct. 25, 2019, PCT No. PCT/KR2019/014164
§ 371(c)(1), (2) Date May 25, 2021,
PCT Pub. No. WO2020/111524, PCT Pub. Date Jun. 4, 2020.
Claims priority of application No. 10-2018-0151990 (KR), filed on Nov. 30, 2018.
Prior Publication US 2022/0002312 A1, Jan. 6, 2022
Int. Cl. C07D 491/20 (2006.01)
CPC C07D 491/20 (2013.01) [C07B 2200/13 (2013.01)] 15 Claims
 
1. A dibesylate salt of the compound of Formula 1:

OG Complex Work Unit Chemistry